Exergaming Revolution in Dementia
Recruiting · NCT06631742 · Interventional (participants receive a specific treatment) · Lead sponsor: Eastern Switzerland University of Applied Sciences
View the official record on ClinicalTrials.gov →Interventions studied
Exergaming on Dividat SensoUsual Care
What this trial is about
This pilot randomized controlled trial evaluates the effect of a 12 weeks exergaming training in people with major neurocognitive disorders (MNCD) living in long-term care facilities.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Neurocognitive disorder based on Alzheimer's Disease, Parkinson's disease, Lewy body dementia or Mixed dementia according to the criteria of the American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5)
- Mini-Mental-Status-Examination (MMSE) Score of ≥5 and ≤26 out of e maximum of 30
Exclusion criteria
- MMSE \<5
- Unstable cardiovascular condition or other medical condition that does not allow for safe participation according to the recommendations of the American College of Sports Medicine
- Planned transfer to another facility within the next 3 months
- Acute behavioural problems
Where it is running
1 location listed.
- Sonnweid AG - Wetzikon, Canton of Zurich, Switzerland